Coming Soon
Find comprehensive information on pancreatic mass diagnosis, including clinical documentation, medical coding (ICD-10, CPT), differential diagnosis, symptoms, and treatment options. Learn about imaging studies for pancreatic masses such as CT scans, MRIs, and endoscopic ultrasounds. Explore resources for healthcare professionals on pancreatic cancer vs. other pancreatic masses, pancreatic cyst, pancreatic neuroendocrine tumor, and solid pseudopapillary neoplasm. This resource provides valuable insights into the diagnosis and management of pancreatic masses for clinicians and patients.
Also known as
Malignant neoplasm of pancreas
Cancerous tumors affecting the pancreas.
Benign neoplasm of pancreas
Non-cancerous tumors in the pancreas.
Secondary malignant neoplasm of pancreas
Cancer that has spread to the pancreas from another site.
Unspecified pancreatic mass
An abnormal growth or lump in the pancreas, not otherwise specified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the pancreatic mass specified as cystic?
When to use each related code
| Description |
|---|
| Pancreatic Mass |
| Pancreatic Cyst |
| Pancreatic Pseudocyst |
Coding pancreatic mass without specifying head, body, tail, or other location leads to inaccurate DRG assignment and reimbursement.
Failing to document whether the mass is benign, uncertain behavior, in-situ, or malignant impacts coding and quality reporting.
Insufficient documentation linking symptoms, imaging findings, and diagnostic procedures to support the pancreatic mass diagnosis can trigger audits.
Patient presents with concerning symptoms suggestive of a pancreatic mass. These include (but are not limited to) abdominal pain, jaundice, weight loss, back pain, nausea, vomiting, and changes in stool. Physical examination may reveal abdominal tenderness, palpable mass, or signs of jaundice. Differential diagnosis includes pancreatic adenocarcinoma, pancreatic neuroendocrine tumor, pancreatic cyst, pseudocyst, and other less common pancreatic neoplasms. Initial workup includes laboratory studies such as complete blood count (CBC), comprehensive metabolic panel (CMP), liver function tests (LFTs), tumor markers (CA 19-9), and coagulation studies. Imaging studies are crucial for evaluation and may include abdominal ultrasound, computed tomography (CT) scan with pancreatic protocol, magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for tissue biopsy if indicated. Further management depends on the characteristics of the mass, including size, location, morphology, and biopsy results. Treatment options may include surgical resection (Whipple procedure, distal pancreatectomy), chemotherapy, radiation therapy, or a combination thereof. Patient education regarding pancreatic cancer symptoms, pancreatic mass diagnosis, and pancreatic cancer treatment options is essential. Referral to a gastroenterologist, surgical oncologist, medical oncologist, andor interventional radiologist may be necessary for comprehensive care and treatment planning. Follow-up and surveillance are critical for monitoring disease progression and response to therapy. This documentation supports medical coding for pancreatic mass evaluation and management, including appropriate ICD-10 and CPT codes for billing purposes.